← Back to Clinical Trials
Recruiting NCT06316167

Mandatory Hiatoplasty in Sleeve Gastrectomy for Gastro-Esophageal Reflux Disease

Trial Parameters

Condition Postgastrectomy Syndromes
Sponsor Instituto Mexicano del Seguro Social
Study Type OBSERVATIONAL
Phase N/A
Enrollment 275
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-03-01
Completion 2024-07-31

Brief Summary

The goal of this observational study is to learn about incidence of postoperative gastroesophageal reflux disease in mandatory hiatoplasty performed during gastric sleeve surgery. The main question\[s\] it aims to answer are: * Incidence of postoperative GERD in patients undergoing gastric sleeve with mandatory hiatoplasty * Comparison of postoperative complication rates, including GERD Participants will answer a follow-up questionnaire, about postoperative quality of life

Eligibility Criteria

Inclusion Criteria: * Patients over 18 years of age. * Gender indistinct. * Overweight, obesity grade I, II, III, super obesity or super-super obesity. * Underwent gastric sleeve with hiatoplasty for obesity management at a high volume Tijuana hospital dedicated to bariatric surgery. Exclusion Criteria: * Patient records with incomplete information.

Related Trials